"Legal Battle: Lawsuit Targets Ozempic and Mounjaro for Alleged Side Effects"

A lawsuit has been filed against the manufacturers of weight loss drugs Ozempic and Mounjaro, claiming that they failed to adequately warn consumers about the alleged risk of severe gastrointestinal side effects. The lawsuit involves a woman with a history of diabetes who experienced severe vomiting, stomach pain, and gastrointestinal burning after taking the medications. While both drugs are approved by the FDA to treat Type 2 diabetes, some doctors prescribe them off-label for weight loss. The manufacturers, Eli Lilly and Novo Nordisk, maintain that gastrointestinal events are known side effects and that the drugs have been extensively studied.